Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial

Autor: Sculier, Delphine, Wandeler, Gilles, Yerly Ferrillo, Sabine, Marinosci, Annalisa, Stoeckle, Marcel, Bernasconi, Enos, Braun, Dominique L., Vernazza, Pietro, Cavassini, Matthias, Buzzi, Marta, Metzner, Karin J., Decosterd, Laurent A., Günthard, Huldrych F., Schmid, Patrick, Limacher, Andreas, Egger, Matthias, Calmy, Alexandra, Swiss HIV Cohort Study (SHCS)

Publikováno v: PLoS Medicine
PLOS Medicine, Vol. 17, No 11 (2020) P. e1003421
PLoS Medicine, Vol 17, Iss 11, p e1003421 (2020)
PLoS medicine, vol. 17, no. 11, pp. e1003421
Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Marinosci, Annalisa; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent A; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Egger, Matthias; Calmy, Alexandra (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial. PLoS medicine, 17(11), e1003421. Public Library of Science 10.1371/journal.pmed.1003421

Background Dolutegravir (DTG)–based dual therapy is becoming a new paradigm for both the initiation and maintenance of HIV treatment. The SIMPL’HIV study investigated the outcomes of virologically suppressed patients on standard combination antir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bdd4c65511c7d667a0d2980ff73e398
https://pubmed.ncbi.nlm.nih.gov/33170863

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Syndrome de renutrition inappropriée : aspects pratiques

Autor: Buzzi, Marta, Limonta, Alessandro Luigi, Pichard, Claude, Stirnemann, Jérôme

Publikováno v: Revue médicale suisse, Vol. 11, No 490 (2015) pp. 1886-1891

Le syndrome de renutrition inappropriée est fréquent et potentiellement mortel, mais reste sous-diagnostiqué. Il est défini par l'ensemble des manifestations clinico-biologiques qui surviennent lors de la renutrition du patient dénutri. Il est l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1400::a353b9aac34e37e440dfc8c14e87aa0f
https://archive-ouverte.unige.ch/unige:87454

Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.

Autor: Marinosci A; HIV/AIDS Unit, Department of Infectious Diseases, Geneva University Hospitals, and the University of Geneva Faculty of Medicine, Geneva, Switzerland., Sculier D; HIV/AIDS Unit, Department of Infectious Diseases, Geneva University Hospitals, and the University of Geneva Faculty of Medicine, Geneva, Switzerland.; Private Practice Office, Geneva, Switzerland., Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Yerly S; Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland., Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, University of Basel, Basel, Switzerland., Bernasconi E; Service of Infectious Diseases, Lugano Regional Hospital, Lugano, Switzerland., Braun DL; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Vernazza P; Division of Infectious Diseases and Hospital Epidemiology, Kantonspital St.Gallen, St. Gall, Switzerland., Cavassini M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland., Buzzi M; HIV/AIDS Unit, Department of Infectious Diseases, Geneva University Hospitals, and the University of Geneva Faculty of Medicine, Geneva, Switzerland., Metzner KJ; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Decosterd L; Pharmacology Laboratory, Clinical Pharmacology Department, University of Lausanne, Lausanne, Switzerland., Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Schmid P; Division of Infectious Diseases and Hospital Epidemiology, Kantonspital St.Gallen, St. Gall, Switzerland., Limacher A; CTU Bern, University of Bern, Bern, Switzerland., Branca M; CTU Bern, University of Bern, Bern, Switzerland., Calmy A; HIV/AIDS Unit, Department of Infectious Diseases, Geneva University Hospitals, and the University of Geneva Faculty of Medicine, Geneva, Switzerland.

Publikováno v: Swiss medical weekly [Swiss Med Wkly] 2024 Apr 15; Vol. 154, pp. 3762. Date of Electronic Publication: 2024 Apr 15.